Related references
Note: Only part of the references are listed.The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China
David S. Hui et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
The pandemic pipeline
John Hodgson
NATURE BIOTECHNOLOGY (2020)
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model
Anwar M. Hashem et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas
Danielle R. Adney et al.
VIRUSES-BASEL (2019)
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2019)
Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice
Hirofumi Kato et al.
PLOS ONE (2019)
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
Naif Khalaf Alharbi et al.
SCIENTIFIC REPORTS (2019)
Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism
Craig Schindewolf et al.
VIRUSES-BASEL (2019)
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
Mun Peak Nyon et al.
VACCINE (2018)
Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
Yao Deng et al.
EMERGING MICROBES & INFECTIONS (2018)
Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
Fan Luo et al.
VIROLOGICA SINICA (2018)
Multivalent and Multipathogen Viral Vector Vaccines
Katharina B. Lauer et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC
William J. Liu et al.
JOURNAL OF IMMUNOLOGY (2017)
One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus
Christoph Wirblich et al.
JOURNAL OF VIROLOGY (2017)
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
Naif Khalaf Alharbi et al.
VACCINE (2017)
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
Christopher M. Coleman et al.
VACCINE (2017)
DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice
Hang Chi et al.
VACCINE (2017)
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection
Yufei Wang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
Katherine V. Houser et al.
PLOS PATHOGENS (2017)
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
Vincent J. Munster et al.
NPJ VACCINES (2017)
Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses
Jingxian Zhao et al.
SCIENCE IMMUNOLOGY (2017)
Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus
Akane Urakami et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
Naru Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
Bart L. Haagmans et al.
SCIENCE (2016)
Vaccines for the prevention against the threat of MERS-CoV
Lanying Du et al.
EXPERT REVIEW OF VACCINES (2016)
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Jincun Zhao et al.
IMMUNITY (2016)
A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
Wanbo Tai et al.
VIROLOGY (2016)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
Anurodh Shankar Agrawal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity
Chan-Ki Min et al.
SCIENTIFIC REPORTS (2016)
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
Daniel C. Payne et al.
EMERGING INFECTIOUS DISEASES (2016)
Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
Xiaojuan Guo et al.
IMMUNOLOGY (2015)
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Jasper Fuk-Woo Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
Anna H. Malczyk et al.
JOURNAL OF VIROLOGY (2015)
Severe Acute Respiratory Syndrome Coronaviruses with Mutations in the E Protein Are Attenuated and Promising Vaccine Candidates
Jose A. Regla-Nava et al.
JOURNAL OF VIROLOGY (2015)
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
Asisa Volz et al.
JOURNAL OF VIROLOGY (2015)
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Kristen E. Pascal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
Karuppiah Muthumani et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
Troy C. Sutton et al.
VIROLOGY (2015)
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang et al.
NATURE COMMUNICATIONS (2015)
Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine
Yiling Zhang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
Jian Tang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo
Steven M. Blaauboer et al.
ELIFE (2015)
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge
Jiaming Lan et al.
EBIOMEDICINE (2015)
Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
Yoshikazu Honda-Okubo et al.
JOURNAL OF VIROLOGY (2015)
Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea
Wan Beom Park et al.
EMERGING INFECTIOUS DISEASES (2015)
Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses
Sudhakar Agnihothram et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
Jiaming Lan et al.
PLOS ONE (2014)
Rapid generation of a mouse model for Middle East respiratory syndrome
Jincun Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
Eun Kim et al.
VACCINE (2014)
Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
Cuiqing Ma et al.
VACCINE (2014)
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
Christopher M. Coleman et al.
VACCINE (2014)
Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
Shuai Xia et al.
VIRUS RESEARCH (2014)
Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
Darryl Falzarano et al.
PLOS PATHOGENS (2014)
Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein
Craig Fett et al.
JOURNAL OF VIROLOGY (2013)
Pneumonia from Human Coronavirus in a Macaque Model
Vincent J. Munster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
Fernando Almazan et al.
MBIO (2013)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
Byoung-Shik Shim et al.
VIROLOGY JOURNAL (2012)
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Fang Tang et al.
JOURNAL OF IMMUNOLOGY (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice
Jincun Zhao et al.
JOURNAL OF VIROLOGY (2010)
Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease
Jason Netland et al.
VIROLOGY (2010)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
Raymond H. See et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
Kumari G. Lokugamage et al.
VACCINE (2008)
Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
Lanying Du et al.
VACCINE (2008)
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E. Martin et al.
VACCINE (2008)
Priming with SARS CoVS DNA and boosting with SARS CoVS epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses
Jun Huang et al.
VACCINE (2007)
Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens
Joshua M. DiNapoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
Lanying Du et al.
VACCINE (2007)
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII- dependent entry into B cells in vitro
Yin Wing Kam et al.
VACCINE (2007)
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: Implications for a subunit vaccine
Alexander N. Zakhartchouk et al.
VACCINE (2007)
Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus
Taisheng Li et al.
PLOS ONE (2006)
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
Damon Deming et al.
PLOS MEDICINE (2006)
Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients
Hui Peng et al.
VIROLOGY (2006)
Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design
Yuxian He et al.
JOURNAL OF VIROLOGY (2006)
Cynomolgus macaque as an animal model for severe acute respiratory syndrome
James V. Lawler et al.
PLOS MEDICINE (2006)
A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice
ZM Zhou et al.
VACCINE (2006)
Nidovirales:: Evolving the largest RNA virus genome
AE Gorbalenya et al.
VIRUS RESEARCH (2006)
Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome
W Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus
RH See et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine
E Qin et al.
VACCINE (2006)
Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization
WP Kong et al.
JOURNAL OF VIROLOGY (2005)
Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
SU Kapadia et al.
VIROLOGY (2005)
SARS vaccine protective in mice
K Stadler et al.
EMERGING INFECTIOUS DISEASES (2005)
Multiple organ infection and the pathogenesis of SARS
J Gu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
J Zhou et al.
VACCINE (2005)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region
ZW Chen et al.
JOURNAL OF VIROLOGY (2005)
Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice
TC Greenough et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system
SX Wang et al.
JOURNAL OF VIROLOGY (2005)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice
K Subbarao et al.
JOURNAL OF VIROLOGY (2004)
Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
J McAuliffe et al.
VIROLOGY (2004)
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
A Bukreyev et al.
LANCET (2004)
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
YX He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
H Weingartl et al.
JOURNAL OF VIROLOGY (2004)
Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice
L Tang et al.
DNA AND CELL BIOLOGY (2004)
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
N Takasuka et al.
INTERNATIONAL IMMUNOLOGY (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Share Paper
